A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...
Investor's Business Daily on MSN2d
AnaptysBio Whipsaws On Promising Results In Rheumatoid Arthritis TreatmentAnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.
Ulcerative colitis is a chronic, immune-mediated disorder of the colon and rectum characterized by mucosal inflammation that damages the bowel wall surface. Current therapeutic options include ...
Palisade Bio (PALI) announced the presentation of positive preclinical data from PALI-2108, an orally administered, colon-specific ...
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
Ongoing research into ulcerative colitis continues to uncover new treatment options, therapies, and ways to improve patient outcomes. Advances in biologic treatments and personalized medicine hold ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease and ulcerative colitis, is the company's latest step into the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback